Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Current Pharmaceutical Analysis is Scopus-indexed (Q3, CiteScore 2.7), WoS SCIE. Published by KeAi Communications Co..
Checked against the index lists dated .
ISSN 1573-4129Verify ISSN ↗1875-676XVerify ISSN ↗
Publisher: KeAi Communications Co.
Cost to publish: About US$2,100 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 103 / 191 | 46th | Q3 |
| Biophysics | 103 / 155 | 33rd | Q3 |
| Biochemistry | 333 / 448 | 25th | Q3 |
| Molecular Medicine | 147 / 179 | 18th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2006–present, best quartile Q3, CiteScore 2.7.
Current Pharmaceutical Analysis is Q3 in Pharmaceutical Science (rank 103 of 191), Q3 in Biophysics (rank 103 of 155) and Q3 in Biochemistry (rank 333 of 448), by CiteScore 2025. It is ranked in 4 subject areas in all.
Current Pharmaceutical Analysis is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.7, which places it in quartile Q3 at the 46th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.442, quartile Q2, with an H-index of 32.
The publisher lists an article processing charge of about US$2,100 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Current Pharmaceutical Analysis is published by KeAi Communications Co. Its print ISSN is 1573-4129 and its online ISSN is 1875-676X.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Current Pharmaceutical Analysis has an h-index of 35 and a 2-year mean of 4.08 citations per paper (OpenAlex). Its Scopus CiteScore is 2.7, quartile Q3. On 2-year citations it ranks #40 of 177 Scopus journals in Pharmaceutical Science.
Current Pharmaceutical Analysis published 57 papers in 2025; its busiest recent year was 2018 with 139. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 87 research articles (2025–2026), authors are most often from China (56.9%), India (16.5%) and Nigeria (3.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (0.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.